0001209191-17-034076.txt : 20170519
0001209191-17-034076.hdr.sgml : 20170519
20170519185745
ACCESSION NUMBER: 0001209191-17-034076
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170516
FILED AS OF DATE: 20170519
DATE AS OF CHANGE: 20170519
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: G1 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001560241
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263648180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 79 T.W. ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-213-9835
MAIL ADDRESS:
STREET 1: P. O. BOX # 110341
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: G-Zero Therapeutics, Inc.
DATE OF NAME CHANGE: 20121012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moses Jennifer K.
CENTRAL INDEX KEY: 0001706667
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38096
FILM NUMBER: 17859429
MAIL ADDRESS:
STREET 1: 79 TW ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
3/A
1
doc3a.xml
FORM 3/A SUBMISSION
X0206
3/A
2017-05-16
2017-05-16
0
0001560241
G1 Therapeutics, Inc.
GTHX
0001706667
Moses Jennifer K.
C/O G1 THERAPEUTICS, INC.
79 T.W. ALEXANDER DRIVE
RESEARCH TRIANGLE PARK
NC
27709
0
1
0
0
VP of Finance & Admin
Stock Option (Right to Buy)
4.17
2026-05-10
Common Stock
60000
D
The shares underlying this option vest as to 25% of the shares on May 10, 2017, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
The number of underlying shares of common stock and the exercise price reported reflect a 1-for-3 reverse stock split of the Issuer's common stock effected on May 11, 2017.
This amendment is being filed to correct the exercise price of this stock option. The original filing on May 16, 2017 noted that the exercise price was $4.19. The correct exercise price is $4.17.
/s/ Caroline G. Gammill, attorney-in-fact
2017-05-19